The elevation of cyclic GMP as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides
- 1 September 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 129 (1-2) , 165-168
- https://doi.org/10.1016/0014-2999(86)90348-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The use of a monoclonal antibody to measure plasma atriopeptins in ratLife Sciences, 1986
- Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the HumanScience, 1986
- The Renal Response to Acute Hypervolemia is Caused by Atrial Natriuretic PeptidesJournal of Cardiovascular Pharmacology, 1986
- RAPID INCREASE IN PLASMA AND URINARY CYCLIC GMP AFTER BOLUS INJECTION OF ATRIAL NATRIURETIC FACTOR IN MANJournal of Clinical Endocrinology & Metabolism, 1985
- The Heart and the Atrial Natriuretic Factor*Endocrine Reviews, 1985
- Increased plasma cyclic nucleotide concentrations in congestive heart failure.Heart, 1984
- Effect of native and synthetic atrial natriuretic factor on cyclic GMPBiochemical and Biophysical Research Communications, 1984
- Developmental changes in the effect of morphine, epinephrine and carbachol on plasma cyclic nucleotide level iin ratsEuropean Journal of Pharmacology, 1983
- Plasma cyclic GMP: Response to cholinergic agentsEuropean Journal of Pharmacology, 1978
- Radioimmunoassay for Cyclic NucleotidesJournal of Biological Chemistry, 1972